Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks

​​

Principal Investigator, Dr. Duygu Tosun-Turgut, co-published the study titled, “Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks”, which presents new Alzheimer’s research exploring whether blood tests can reveal not just the presence of brain changes related to the disease but also when they begin and how they progress.

​

Study results from the Foundation for the National Institutes of Health’s Plasma Aβ project, published in Annals of Neurology, demonstrate that only one blood biomarker becomes abnormal very early, while others show up later and can be used to reliably track disease stage and progression. The findings suggest that blood tests could be used to enhance clinical trial design, guide treatment strategies, and ultimately improve outcomes for patients.

 

Read more: https://onlinelibrary.wiley.com/doi/10.1002/ana.27285